ORAL ANTIHISTAMINE OR NASAL STEROID IN HAY-FEVER - A DOUBLE-BLIND DOUBLE-DUMMY COMPARATIVE-STUDY OF ONCE DAILY ORAL ASTEMIZOLE VS TWICE DAILY NASAL BECLOMETHASONE DIPROPIONATE

被引：42

|

作者：

WOOD, SF

机构：

来源：

CLINICAL ALLERGY | 1986年 / 16卷 / 03期

关键词：

D O I：

10.1111/j.1365-2222.1986.tb00766.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：195 / 201

页数：7

相关论文

共 50 条

[21] Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis:: A double-blind, double-dummy, randomized, controlled, dose-ranging study
Kruis, Wolfgang
Jonaitis, Laimas
Pokrotnieks, Juris
Acute, Gitana
Mikhailova, Tatyana L.
Horynski, Marek
Batovsky, Marian
Racz, Istvan
Kull, Karin
Faszczyk, Mark
Greinwald, Roland
Mueller, Ralph
GASTROENTEROLOGY, 2008, 134 (04) : A489 - A489
[22] Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: Double-blind, multicenter, randomized study
Tarshis, GA
Miskin, BM
Jones, TM
Champlin, J
Wingert, KJ
Breen, JD
Brown, MJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) : 2358 - 2362
[23] Ibuprofen arginine vs naproxen sodium as prophylactic oral treatment of pain due to dental surgery - A randomised double-blind double-dummy placebo-controlled multicentre study
Borea, G
Monopoli, R
Colantoni, A
CLINICAL DRUG INVESTIGATION, 1996, 11 : 33 - 40
[24] Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial
Shafran, SD
Tyring, SK
Ashton, R
Decroix, J
Forszpaniak, C
Wade, A
Paulet, C
Candaele, D
JOURNAL OF CLINICAL VIROLOGY, 2004, 29 (04) : 248 - 253
[25] Lipid Profiles Over 2 Years Follow-Up in De Novo Kidney Transplant Recipients Randomized to Once-Daily MeltDose® Tacrolimus (Envarsus® XR) Vs. Twice-Daily Tacrolimus (Prograf®): Results from a Phase 3, Double-Blind, Double-Dummy, Multicenter Trial
Mulgaonkar, S.
Pankewycz, O.
Steinberg, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[26] Efficacy, Safety and Pharmacokinetics of Once-Daily, MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus (Prograf®) in De Novo Kidney Transplant Recipient Sub-Groups: A 2 Year Phase 3 Randomized, Double-Blind, Double-Dummy, Trial
Bunnapradist, S.
Denny, J.
Waybill, M.
West-Thielke, P.
Steinberg, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[27] Higher Starting Dose and Rapid Attainment of Tacrolimus Blood Levels With Envarsus Vs. Prograf Is Not Associated With Increased Toxicity: Exploratory Analysis of a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized, Prospective Study of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) Vs. Prograf (Twice-Daily Tacrolimus Capsules)
Tedesco Silva, H., Jr.
Bunnapradist, S.
Steinberg, S.
TRANSPLANTATION, 2014, 98 : 458 - 458
[28] Higher Starting Dose and Rapid Attainment of Tacrolimus Blood Levels With Envarsus Vs. Prograf Is Not Associated With Increased Toxicity: Exploratory Analysis of a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized, Prospective Study of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) Vs. Prograf (Twice-Daily Tacrolimus Capsules).
Silva, H. Tedesco, Jr.
Bunnapradist, S.
Steinberg, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 458 - 458
[29] A DOUBLE-BLIND GROUP COMPARATIVE-STUDY OF OPHTHALMIC SODIUM CROMOGLYCATE, 2-PERCENT 4 TIMES DAILY AND 4-PERCENT TWICE-DAILY, IN THE TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS
LEINO, M
MONTAN, P
NJA, F
ALLERGY, 1994, 49 (03) : 147 - 151
[30] ONCE VS TWICE DAILY ADMINISTRATION OF A FIXED COMBINATION OF CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND CROSSOVER STUDY IN KNOWN RESPONDERS TO A STANDARD COMBINATION
LACOURCIERE, Y
POIRIER, L
PROVENCHER, P
GUIVARCH, PH
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) : 115 - 119

← 1 2 3 4 5 →